πŸ‡ΊπŸ‡Έ FDA
Patent

US 8829025

Anti-cancer compounds

granted A61KA61K2300/00A61K31/43

Quick answer

US patent 8829025 (Anti-cancer compounds) held by Northwestern University expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K2300/00, A61K31/43, A61K31/473, A61K45/06